We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Hogan Lovells’ Pharmaceutical and Biotechnology Practice Gains FDA Lawyer in Washington, D.C.

15 November 2010

WASHINGTON, D.C., 15 November 2010 – Hogan Lovells announced today that it has expanded its Pharmaceutical and Biotechnology practice group with the addition of Lynn Whipkey Mehler, former U.S. Food and Drug Administration (FDA) Senior Counsel for Drugs, as a partner in the Washington, D.C.,* office of Hogan Lovells US LLP.

With 12 years experience at the FDA, Mehler served as one of the principal lawyers to the agency's Center for Drug Evaluation and Research (CDER) and was responsible for supervising the work of a number of lawyers. Mehler has also counseled senior FDA officials on a broad range of legal issues involving federal regulation of pharmaceutical and biotechnology products, including drug safety, drug labeling, risk management, post-marketing studies and trials, and the federal regulation of controlled substances.

Partners within the Hogan Lovells Pharmaceutical and Biotechnology Practice Group are pleased with Mehler’s decision to join Hogan Lovells.

"While at the agency, Lynn was the go-to lawyer for key constituents within CDER," said practice group co-director, Meredith Manning.

Partner David Fox, a former colleague of Mehler’s at FDA, said "Lynn's broad portfolio at the agency has given her not only deep knowledge of the law, but also a nuanced understanding of how agency policies and positions have evolved over the years, which will be invaluable to assisting our clients."

Practice group co-director Philip Katz said, "Because of her knowledge of the hot issues currently confronting FDA – such as PDUFA reauthorization and REMS – Lynn's contributions will be significant. We’re excited to have her join us."

"I look forward to identifying the areas where my experience can bring the most value to Hogan Lovells' tremendously talented Pharmaceutical and Biotechnology group," said Mehler.

Before joining FDA’s Office of the Chief Counsel, Mehler served as a law clerk to the Honorable Glen E. Conrad, U.S. Magistrate Judge for the Western District of Virginia. She received her law degree from the William & Mary School of Law and her bachelor's degree in political science from the College of Wooster.

* Mehler is currently licensed to practice only in Virginia.

The team

 
Loading data